Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 NOK | -6.06% |
|
+2.88% | +91.36% |
05-30 | Transcript : Lytix Biopharma AS, Q1 2024 Earnings Call, May 30, 2024 | |
05-30 | Lytix Biopharma AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Lytix Biopharma
Upcoming events on Lytix Biopharma
Past events on Lytix Biopharma
2024-05-30 07:00 | Q1 2024 Earnings Call |
2024-05-30 02:00 | Q1 2024 Earnings Release |
2024-05-14 07:00 | Annual General Meeting |
2024-02-29 02:00 | Q4 2023 Earnings Release |
2024-02-28 | Q4 2023 Earnings Call |
2024-01-24 05:27 | Redeye Theme: Fight Cancer |
2023-11-23 08:40 | Redeye Life Science Day |
2023-11-13 | BIO Europe Conference |
2023-11-13 | Jefferies London Healthcare Conference |
2023-11-12 | LSX Investival Showcase Conference |
2023-11-09 08:30 | Q3 2023 Earnings Call |
2023-11-09 02:00 | Q3 2023 Earnings Release |
2023-10-31 | Society for Immunotherapy of Cancer Meeting |
2023-10-19 | European Society for Medical Oncology Congress |
2023-10-10 | Optimum Healthcare Investor Conference |
2023-08-31 08:30 | Q2 2023 Earnings Call |
2023-08-31 02:00 | Q2 2023 Earnings Release |
2023-08-27 | ABGSC Cancer Vaccine Seminar |
2023-06-04 | BIO International Convention |
2023-06-01 | American Society of Clinical Oncology Conference |
Annual results
Fiscal Period | December | 2022 | 2023 | 2024 |
---|---|---|---|---|
Net sales Million NOK | Released Forecast Spread | 0,00 | 3,99 0,00 - | 6,30 |
EBITDA Million NOK | Released Forecast Spread | 0,00 | -96,7 -92,0 -5.13% | -70,7 |
EBIT Million NOK | Released Forecast Spread | 0,00 | -96,8 -92,0 -5.2% | -70,7 |
Earnings before Tax (EBT) Million NOK | Released Forecast Spread | -56,0 | -87,9 0,00 - | 0,00 |
Net income Million NOK | Released Forecast Spread | -56,0 | -87,9 0,00 - | 0,00 |
EPS | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
Announcement Date | 16/02/23 | 29/02/24 | - |
2024-07-15 01:45 | ADDLIFE AB: Q2 2024 Earnings Release |
2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
2024-07-25 01:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
2024-07-26 01:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Lytix Biopharma
2024-06-07 02:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
2024-05-29 16:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
2024-05-23 07:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
2024-05-22 01:00 | EVOTEC SE: Q1 2024 Earnings Release |
2024-05-21 17:14 | ALVOTECH: Q1 2024 Earnings Release |
2024-05-21 07:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
2024-05-17 02:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
2024-05-15 16:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- LYTIX Stock
- Calendar Lytix Biopharma